Fisher Asset Management LLC Acquires 161,278 Shares of Core Laboratories Inc. (NYSE:CLB)

Fisher Asset Management LLC raised its holdings in shares of Core Laboratories Inc. (NYSE:CLBFree Report) by 19.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 990,267 shares of the oil and gas company’s stock after purchasing an additional 161,278 shares during the quarter. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $18,350,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Headlands Technologies LLC purchased a new position in Core Laboratories in the 2nd quarter worth about $36,000. nVerses Capital LLC purchased a new position in shares of Core Laboratories during the third quarter worth approximately $48,000. GAMMA Investing LLC raised its stake in shares of Core Laboratories by 23.9% during the second quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock valued at $90,000 after acquiring an additional 855 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Core Laboratories by 11.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 600 shares during the period. Finally, Signaturefd LLC grew its stake in Core Laboratories by 12.8% in the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock worth $137,000 after purchasing an additional 767 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Trading Down 0.6 %

Shares of NYSE:CLB opened at $20.43 on Thursday. The company has a market capitalization of $959.19 million, a PE ratio of 31.43, a P/E/G ratio of 1.40 and a beta of 2.35. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a 12-month low of $13.82 and a 12-month high of $25.13. The business’s fifty day simple moving average is $19.38 and its 200-day simple moving average is $19.52.

Core Laboratories (NYSE:CLBGet Free Report) last announced its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million during the quarter, compared to the consensus estimate of $134.16 million. During the same period in the previous year, the company posted $0.22 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. As a group, equities research analysts predict that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.20%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s dividend payout ratio is currently 6.15%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CLB. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup lowered their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, Core Laboratories has a consensus rating of “Hold” and an average price target of $17.00.

Get Our Latest Report on CLB

Core Laboratories Profile

(Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Featured Articles

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLBFree Report).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.